v3.26.1
Discontinued operations (Tables)
12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of discontinued operation of financial statements

Reconciliation of the amounts of major classes of income and losses from discontinued operations in the consolidated statements of operations for the years ended December 31, 2025, 2024 and 2023 are as follows:

 

 

   2025   2024   2023 
   For the Years Ended December 31, 
   2025   2024   2023 
             
REVENUE  $-   $-   $992,791 
                
COST OF REVENUE   -    -    800,185 
                
GROSS PROFIT   -    -    192,606 
                
OPERATING EXPENSES               
Selling   -    13,209    217,122 
General and administrative   -    285,982    1,562,114 
Research and development   -    -    19,187 
TOTAL OPERATING EXPENSES   -    299,191    1,798,423 
                
LOSS FROM OPERATIONS   -    (299,191)   (1,605,817)
                
OTHER INCOME, NET   -    2,545,640    5,532 
                
INCOME (LOSS) BEFORE INCOME TAXES   -    2,246,449    (1,600,285)
                
PROVISION FOR INCOME TAXES   -    109    1,038 
                
NET INCOME (LOSS) ATTRIBUTABLE TO EUDA  $-   $2,246,340   $(1,601,323)

 

 

EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(In U.S. dollars, unless stated otherwise)

 

Reconciliation of the amount of cash flows from discontinued operations in the consolidated statements of cash flows for the years ended December 31, 2025, 2024 and 2023 are as follows:

 

   2025   2024   2023 
   For the Years Ended December 31, 
   2025   2024   2023 
             
Net cash (used in) provided by operating activities from discontinued operations  $-   $(9,155)  $295,967 
                
Net cash used in investing activities from discontinued operations  $-   $(3,148)  $- 
                
Net cash provided by (used in) financing activities from discontinued operations  $-   $256,088   $(371,888)